findmyKOL

Radhika Bukkapatnam, MD

Basic profile

University of California Davis Medical Center

ORCIDNone on fileNPI
RegionElk Grove, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Radhika Bukkapatnam is a Cardiology physician affiliated with University of California Davis Medical Center. OpenAlex indexes 7 publications with 225 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

225citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8110 Laguna Blvd
Elk Grove, CA 957587904

Telephone

916-683-3950

Registry record last updated 21 Jan 2009.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    84.3%
    Beta blocker20.7%
    Metoprolol Succinate44%Metoprolol Tartrate21%Carvedilol19%Bisoprolol Fumarate6%Atenolol4%Propranolol Hcl Er2%Sotalol1%Nebivolol Hcl1%Propranolol Hcl1%Bisoprolol-Hydrochlorothiazide1%Carvedilol Er0%
    Part D<11 patients
    Statin16.5%
    Atorvastatin Calcium67%Rosuvastatin Calcium27%Pravastatin Sodium5%Simvastatin1%Lovastatin1%
    Part D<11 patients

    + 20 more classes in this area

  • Blood & clotting

    11.3%
    Factor Xa inhibitor9.1%
    Eliquis85%Xarelto15%
    Part D271 patients
    P2Y12 inhibitor2%
    Clopidogrel90%Brilinta10%
    Part D81 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    4.3%
    Potassium supplement2.1%
    Potassium Chloride90%Klor-Con 1010%
    Part D<11 patients
    SGLT2 inhibitor1.9%
    Jardiance88%Farxiga12%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)12.4% facility · 87.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”